ATE451925T1 - Medizinische zusammensetzung, verfahren zu ihrer herstellung und verfahren zur stabilisierung einer dihydropyridin-verbindung in einer medizinischen zusammensetzung - Google Patents

Medizinische zusammensetzung, verfahren zu ihrer herstellung und verfahren zur stabilisierung einer dihydropyridin-verbindung in einer medizinischen zusammensetzung

Info

Publication number
ATE451925T1
ATE451925T1 AT05790185T AT05790185T ATE451925T1 AT E451925 T1 ATE451925 T1 AT E451925T1 AT 05790185 T AT05790185 T AT 05790185T AT 05790185 T AT05790185 T AT 05790185T AT E451925 T1 ATE451925 T1 AT E451925T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
dihydropyridine compound
medical composition
stabilizing
dihydropyridine
Prior art date
Application number
AT05790185T
Other languages
English (en)
Inventor
Toshio Suzuki
Masanobu Yasui
Satoshi Sugawara
Yutaka Morita
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36142733&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE451925(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Application granted granted Critical
Publication of ATE451925T1 publication Critical patent/ATE451925T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT05790185T 2004-10-06 2005-10-05 Medizinische zusammensetzung, verfahren zu ihrer herstellung und verfahren zur stabilisierung einer dihydropyridin-verbindung in einer medizinischen zusammensetzung ATE451925T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004293771 2004-10-06
PCT/JP2005/018474 WO2006038661A1 (ja) 2004-10-06 2005-10-05 医薬組成物及びその製造方法、並びに医薬組成物におけるジヒドロピリジン系化合物の安定化方法

Publications (1)

Publication Number Publication Date
ATE451925T1 true ATE451925T1 (de) 2010-01-15

Family

ID=36142733

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05790185T ATE451925T1 (de) 2004-10-06 2005-10-05 Medizinische zusammensetzung, verfahren zu ihrer herstellung und verfahren zur stabilisierung einer dihydropyridin-verbindung in einer medizinischen zusammensetzung

Country Status (7)

Country Link
US (1) US20080095841A1 (de)
EP (1) EP1813274B1 (de)
JP (1) JP4509118B2 (de)
CN (1) CN101068546A (de)
AT (1) ATE451925T1 (de)
DE (1) DE602005018387D1 (de)
WO (1) WO2006038661A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008044870A (ja) * 2006-08-11 2008-02-28 Elmed Eisai Kk 医薬組成物及びその製造方法
CN101646461A (zh) * 2007-03-13 2010-02-10 大日本住友制药株式会社 口腔崩解片
JP5683058B2 (ja) * 2007-04-27 2015-03-11 ニプロ株式会社 経口固形製剤及びその製造方法
WO2010014727A1 (en) 2008-08-01 2010-02-04 The Medicines Company Pharmaceutical compositions and methods for producing low impurity concentrations of the same
CN102186351A (zh) * 2008-08-01 2011-09-14 医药公司 药物组合物和用于稳定药物组合物的方法
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
JP4954961B2 (ja) * 2008-10-06 2012-06-20 大日本住友製薬株式会社 光安定性の向上した組成物
CA2740476C (en) 2008-10-24 2016-04-05 Toray Industries, Inc. Stable tablet containing 4,5-epoxymorphinan derivative
JP6081058B2 (ja) * 2009-03-19 2017-02-15 第一三共株式会社 包装により安定保存された固形製剤
EA021317B1 (ru) * 2009-06-30 2015-05-29 Санофи Монослойные таблетки, содержащие ирбесартан и амлодипин, их получение и их терапевтическое применение
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
CN102266337A (zh) * 2010-06-04 2011-12-07 张兆勇 一种盐酸贝尼地平固体制剂及其制备方法
US8658676B2 (en) 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
JP6041591B2 (ja) * 2011-09-13 2016-12-14 大日本住友製薬株式会社 イルベサルタンとアムロジピンまたはその塩を含有する安定化された医薬組成物
JP5689052B2 (ja) * 2011-12-26 2015-03-25 大日本住友製薬株式会社 光安定性の向上した組成物
CN102688237A (zh) * 2012-04-11 2012-09-26 迪沙药业集团有限公司 一种稳定的阿折地平组合物
DK2851075T3 (da) 2012-05-14 2022-01-31 Shionogi & Co Præparat, der indeholder 6,7-umættet -7-carbamoylmorphinanderivat
JP5689192B2 (ja) * 2014-02-21 2015-03-25 大日本住友製薬株式会社 光安定性の向上した組成物
JP6590822B2 (ja) * 2014-10-10 2019-10-16 エーザイ・アール・アンド・ディー・マネジメント株式会社 縮合アミノジヒドロチアジン誘導体の医薬組成物
JP2016033144A (ja) * 2015-11-20 2016-03-10 大日本住友製薬株式会社 光安定性の向上した組成物
JP2020075869A (ja) * 2018-11-05 2020-05-21 日本ケミファ株式会社 カルシウム拮抗剤及びアンジオテンシンｉｉ受容体拮抗剤を有効成分として含有する錠剤
JP6592175B2 (ja) * 2018-12-25 2019-10-16 大日本住友製薬株式会社 光安定性の向上した組成物
US12097189B1 (en) 2024-02-09 2024-09-24 Astellas Pharma Inc. Pharmaceutical composition for modified release
CN120346168B (zh) * 2025-06-25 2025-08-29 浙江大学 一种提高二甲双胍和恩格列净药物复方制剂混合均匀度的方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5758609A (en) * 1980-09-26 1982-04-08 Kaken Pharmaceut Co Ltd Drug containing nifedipine
DE3142853A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen mit nifedipin und verfahren zu ihrer herstellung
EP0078430B2 (de) * 1981-10-29 1993-02-10 Bayer Ag Verfahren zur Herstellung von festen, schnellfreisetzenden Arzneizubereitungen mit Dihydropyridinen
JP3179658B2 (ja) * 1994-07-07 2001-06-25 株式会社三共製作所 錠剤製造方法およびその装置
US5672364A (en) * 1994-07-07 1997-09-30 Sankyo Seisakusho Co. & Eisai Co., Ltd. Apparatus for manufacturing tablets
TW487582B (en) * 1995-08-11 2002-05-21 Nissan Chemical Ind Ltd Method for converting sparingly water-soluble medical substance to amorphous state
KR100457273B1 (ko) * 1996-03-18 2005-04-08 닛산 가가쿠 고교 가부시키 가이샤 에포니디핀염산염제제의제조방법
GT199800127A (es) * 1997-08-29 2000-02-01 Combinaciones terapeuticas.
TW585786B (en) * 1998-07-28 2004-05-01 Takeda Chemical Industries Ltd Lansoprazole-containing rapidly disintegrable solid pharmaceutical composition
JP2000191516A (ja) * 1998-10-23 2000-07-11 Taisho Pharmaceut Co Ltd 経口固形組成物
DE19912623A1 (de) * 1999-03-20 2000-09-28 Lohmann Therapie Syst Lts Verfahren zur Erhöhung der Stabilität bei Lagerung und/oder Anwendung lichtempfindlicher therapeutischer Systeme oder deren Bestandteile
US20030102246A1 (en) * 1999-03-20 2003-06-05 Lts Lohmann Therapie-Systeme Ag Method for improving the stability of stored and/or used light-sensitive therapeutic systems or components thereof
PT1260215E (pt) * 2000-03-01 2009-09-03 Eisai R&D Man Co Ltd Comprimido de desintegração rápida que contém poli(álcool vinílico)
US6872405B2 (en) * 2001-05-10 2005-03-29 Yamanouchi Pharmaceutical Co., Ltd. Quick-disintegrating tablet in buccal cavity and manufacturing method thereof
JP2003034655A (ja) * 2001-05-15 2003-02-07 Takeda Chem Ind Ltd 速崩壊性固形製剤
JP2003104888A (ja) * 2001-09-28 2003-04-09 Taiyo Yakuhin Kogyo Kk ジヒドロピリジン誘導体の錠剤
AR037565A1 (es) * 2001-11-21 2004-11-17 Synthon Bv Formas de sales de amlodipina y procedimientos para prepararlas.
AU2003201071A1 (en) * 2002-01-15 2003-07-30 Ranbaxy Laboratories Limited Stable pharmaceutical compositions comprising ace inhibitor(s)
EG24716A (en) * 2002-05-17 2010-06-07 Novartis Ag Combination of organic compounds
BR0315194A (pt) * 2002-10-31 2005-08-23 Umd Inc Composições terapêuticas para liberação de droga para a, e através da, cobertura epitelial
JP5072748B2 (ja) * 2007-07-10 2012-11-14 株式会社 メドレックス アムロジピンの安定な液剤とゼリー剤

Also Published As

Publication number Publication date
EP1813274A1 (de) 2007-08-01
US20080095841A1 (en) 2008-04-24
JPWO2006038661A1 (ja) 2008-05-15
JP4509118B2 (ja) 2010-07-21
DE602005018387D1 (de) 2010-01-28
CN101068546A (zh) 2007-11-07
WO2006038661A1 (ja) 2006-04-13
EP1813274B1 (de) 2009-12-16
EP1813274A4 (de) 2007-11-07

Similar Documents

Publication Publication Date Title
ATE451925T1 (de) Medizinische zusammensetzung, verfahren zu ihrer herstellung und verfahren zur stabilisierung einer dihydropyridin-verbindung in einer medizinischen zusammensetzung
DE60027728D1 (de) Stabile medizinische zusammensetzungen zur oralen verabreichung unter verwendung von eisenoxiden
WO2004075919A3 (en) Compounds for protein stabilization and methods for their use
ATE522251T1 (de) Toilettenartikel enthaltend eine geordnete wirkstoffabgebende zubereitung und ein verabreichungsvehikel
WO2002067969A3 (en) Stabilized insulin formulations
DE50310614D1 (de) Verfahren zur herstellung von c13-alkoholgemischen
BR0003105A (pt) Compostos de beta-carbolina, processo para sua preparação e composições farmacêuticas contendo os mesmos
DK1897558T3 (da) Fast præparat af 2-hexadecyloxy-6-methyl-4h-3,1-benzoxazin-4-on
MA29653B1 (fr) Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2001271987A1 (en) Non-genotoxic metalloporphyrins as synthetic catalytic scavengers of reactive oxygen species
MXPA04004373A (es) Compuestos heterociclicos condensados con fenilo azabiciclo para el tratamiento de enfermedades.
DK1635792T3 (da) Stabile farmaceutiske sammensætninger af 2-aza-bicyklo-3.3.0-oktan-3-carboxylsyrederivater
MXPA04003986A (es) Carboxamidas hetero-biciclicas n-azabiciclico sustituidas como agonistas nachr.
NZ598467A (en) Stable sns-595 compositions and methods of preparation
DE69803710D1 (de) Langwirkende, injezierbare, parasitizide Zubereitung und Verfahren zu ihrer Herstellung
DE602004001969D1 (de) Orale pharmazeutische Zusammensetzung und Verfahren zu ihrer Herstellung
CA2474246A1 (en) Alkylammonium salts of omeprazole and esomeprazole
ATE405292T1 (de) Injektierbare wässrige paclitaxel-lösungen und verfahren zu ihrer herstellung
WO2005023175A3 (en) Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound
PL1765342T4 (pl) Kompozycja farmaceutyczna zawierająca besylan amlodypiny i dihydrat lizynoprylu oraz sposób jej wytwarzania
DE69501183D1 (de) Feste orale pharmazeutische Zubereitung mit Gemfibrozil als aktiver Inhaltsstoff und Verfahren zur Herstellung
CA2534259A1 (en) Glycyrrhizin high-concentration preparation
WO2009065947A3 (de) Pharmazeutische zusammensetzung, enthaltend eine zeolith/algen- oder zeolith/emulsions-kombination zur behandlung von aids
KR102147785B1 (ko) 수성 폐페인트용 응고제 조성물
JP2834241B2 (ja) 粉体ホスファイト組成物

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties